MIAMI, April 11, 2019 (GLOBE NEWSWIRE) -- Progressive Care Inc. (OTCQB: RXMD), a personalized healthcare services and technology company, today announced that it has garnered media coverage in International Business Times in an op-ed written by S. Parikh Mars, CEO of Progressive Care Inc. titled, Opioid Epidemic: 21st Century Thinking Needed to Solve a 21st Century Problem.
“It is a true honor to have the opportunity to write about a subject very close to my heart. Progressive Care is doing everything in our power to address the opioid crisis,” said S. Parikh Mars, CEO of Progressive Care Inc. “Progressive Care aims to provide alternatives to opioids that suit each patient’s needs in hopes to lower our patient's dependence on opioids and fight the epidemic.”
In the opinion piece titled Opioid Epidemic: 21st Century Thinking Needed To Solve A 21st Century Problem, published April 8, 2019 in International Business Times, Mars discusses that in order to address the opioid epidemic, we must first understand it. Mars says, “ Many states have implemented drastic opioid restrictions, manufacturers and pharmaceutical wholesale vendors have limited supply, pain clinics have shut down and doctors willing to prescribe opioids are fewer and further between. Yet, the problem persists across large swaths of the country and the number of people delivering innovative solutions is dwindling. However, the battle is not lost. The solutions we seek may be right under our noses.”
In the article Mars expressed “we need a new way of thinking about pain to begin with. Currently, pain is evaluated on a 1-10 scale to determine severity and medication is prescribed to address this subjective assessment. However, not all pain is created equally, and no two people feel the same pain the same way.” She concludes that “ To end this crisis, we need to use personalized medicine and a more nuanced view of pain and its treatment. We need to think of pain management in terms of effectiveness and not in terms of strength, choosing non-addictive medicines to address patient-specific pain before resorting to opioid therapies.”
Progressive Care has responded to the opioid epidemic by providing patients with an alternative to opioids, a compound lotion to suit each patient’s needs. The cream hits the target area and helps to relieve pain quickly without having to interact with other medications, and without affecting the liver, and kidney, reducing the risk of addiction or death from taking opioids. Progressive Care Inc.’s wholly owned subsidiary PharmCo, LLC is in the top 10% in the nation evaluated by Humana Inc.and will continue to provide top-of-line services to their patients to fight the opioid epidemic.
The recent media coverage comes after the company’s efforts to provide its network with more healthcare informational resources through PharmCo Pharmacy. Additional commentary from Progressive Care’s CEO about the company and industry as a whole can be found on the Progressive Care blog and PharmCo blog.
For more immediate updates on the company’s media coverage, connect with Progressive Care and PharmCo on social media:
Progressive Care Inc.
https://www.facebook.com/ProgressiveCareUS/
https://twitter.com/ProgressCareUS
PharmCo, LLC
https://www.facebook.com/pharmcorx/
https://twitter.com/PharmCoRx
About Progressive Care Inc.
Progressive Care Inc. (OTCQB: RXMD), through its PharmCo, LLC, is a South Florida health services organization and provider of prescription pharmaceuticals, compounded medications, provider of tele-pharmacy services, the sale of anti-retroviral medications, medication therapy management (MTM), the supply of prescription medications to long-term care facilities, and health practice risk management.
Cautionary Statement Regarding Forward-Looking Statements
Statements contained herein that are not based upon current or historical fact are forward-looking in nature and constitute forward-looking statements within the meaning of Section 27A of the Securities Act of 1933 and Section 21E of the Securities Exchange Act of 1934. Such forward-looking statements reflect the Company’s expectations about its future operating results, performance, and opportunities that involve substantial risks and uncertainties. These statements include but are not limited to statements regarding the intended terms of the offering, closing of the offering and use of any proceeds from the offering. When used herein, the words “anticipate,” “believe,” “estimate,” “upcoming,” “plan,” “target,” “intend” and “expect” and similar expressions, as they relate to Progressive Care Inc., its subsidiaries, or its management, are intended to identify such forward-looking statements. These forward-looking statements are based on information currently available to the Company and are subject to a number of risks, uncertainties, and other factors that could cause the Company's actual results, performance, prospects, and opportunities to differ materially from those expressed in, or implied by, these forward-looking statements.
Public Relations Contact:
Kathleen Gonzales, CMW Media
kathleen@cmwmedia.com
www.cmwmedia.com
Investor Relations Contact:
Armen Karapetyan, Progressive Care
Senior Advisor Business Development
Armen@progressivecareus.com
www.progressivecareus.com
www.pharmcopharmacy.com
Copyright 2022 © Progressive care inc.
Forward-looking Statements – This website contains forward-looking statements about our business. These forward-looking statements do not relate strictly to historical or current facts. Forward-looking statements involve risks and uncertainties and include statements regarding, among other things, our projected revenue growth and profitability, our growth strategies and opportunity, anticipated trends in our market and our anticipated needs for working capital. Forward-looking statements are generally identifiable by the use of words like “may,” “will,” “should,” “anticipate,” “estimate,” “plans,” “potential,” “projects,” “continuing,” “ongoing,” “expects,” “management believes,” “we believe,” “we intend” or the negative of these words or other variations on these words or comparable terminology. You should not put undue reliance on these forward-looking statements. Forward-looking statements are subject to known and unknown risks, uncertainties and other factors that may cause actual results to differ materially from those reflected in such statements including: risks associated with current and potential future healthcare reforms; risks relating to technology failures or breaches; aspects of our business which are outside, risks relating to management and key personnel changes including attracting and retaining key personnel; failure to comply with legal and regulatory requirements; risks relating to access to capital and credit markets; risks related to indebtedness; exposure to claims and liabilities; changes in industry pricing benchmarks; and other risks and uncertainties that are described in the Risk Factors section of our recently filed Form 10-12G, including the presentation of financial statements and notes thereto, and other reports we have filed with the U.S. Securities and Exchange Commission. These reports are available at www.sec.gov or by calling our Investor Relations department at (888) 919-7411 ext. 221. Forward-looking statements speak only as of the date they are posted to this website, unless an earlier date is indicated, and we do not undertake any obligation to publicly update any forward-looking statements, whether as a result of new information, future events or otherwise, except as required by law.
Non-GAAP FinancialMeasures–This presentationincludes certain “non-GAAP financial measures” as defined in Regulation G under the Securities Exchange Act of 1934. Schedules are attached that reconcile the non-GAAP financial measures included in this presentation to the most directly comparable financial measures calculatedand presentedin accordancewith Generally Accepted Accounting Principles in the United States. You should carefully read Progressive Care’s periodic and currentfilings on the OTCQB website for definitions and further explanation and disclosure regarding our use of non-GAAP financial measures and such filings should be read in conjunction with this presentation.
Type your name and email and we'll send you RXMD's investor's presentation in the next few minutes!
.png){kind=logo}
